Ashok Sebastian Komaranchath, Consultant Medical Oncology and Clinical Lead for Oncology Services at Burjeel Cancer Institute, Oman, shared a post on LinkedIn:
“Eagerly looking forward to participating as a speaker in my first overseas Best of ASCO at Muscat, Oman.
I’ll be discussing 3 important trials presented at ASCO 2025, which have attempted to integrate Immune Checkpoint Inhibitors in the neoadjuvant and adjuvant setting of Head and Neck Cancers.
Proud to represent Oman Burjeel Hospital and Burjeel Cancer Institute for this meeting.
Grateful to Ajit Venniyoor for giving me this opportunity.
Looking forward to meeting my friend and newly designated ASTRO Ambassador to the Middle East, Ibrahim Abu-Gheida, during this meeting.”
More posts featuring Ashok Sebastian Komaranchath.
